Myeloid antigen, CD13, CD14, and/or CD33 expression is restricted to certain lymphoid neoplasms

American Journal of Clinical Pathology

Volumn 105, Issue 6, 1996, Pages 761-768

  Nakase, Kazunori ^a   Kita, Kenkichi ^b   Shiku, Hiroshi ^b   Tanaka, Isao ^c   Nasu, Kaori ^d   Dohy, Hiroo ^e   Kyo, Taiichi ^e   Tsutani, Hiroshi ^f   Kamada, Nanao ^g  

^a ISE RED CROSS HOSPITAL   (Japan)

^b MIE UNIVERSITY   (Japan)

^c Suzuka Kaisei Hospital   (Japan)

^d OSAKA RED CROSS HOSPITAL   (Japan)

^e ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

^f UNIVERSITY OF FUKUI   (Japan)

^g HIROSHIMA UNIVERSITY   (Japan)

Author keywords

CD13; CD14; CD33; Lymphoid neoplasm

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; CD15 ANTIGEN; CD33 ANTIGEN; MICROSOMAL AMINOPEPTIDASE;

ADULT; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; B CELL LEUKEMIA; B CELL LYMPHOMA; CHROMOSOME 7; CHROMOSOME TRANSLOCATION 22; CHROMOSOME TRANSLOCATION 9; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; T CELL LEUKEMIA;

EID: 0029892627     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/105.6.761     Document Type: Article

References (36)

1. Griffin JD, Ritz J, Nadler LM, Schlossman SF. Expression of myeloid differentiation antigens on normal and myeloid cells. J Clin Invest 1981;68:932-941.
2. Foon KA, Todd RF. Immunologic classification of leukemia and lymphoma. Blood 1986;68:1-31.
3. Pui C-H, Dahl GV, Melvin S, et al. Acute leukemia with mixed lymphoid and myeloid phenotype. Br J Haematol 1984;56: 121-130.
4. Neame PB, Soamboonsrup P, Browman G, et al. Simultaneous or sequential expression of lymphoid and myeloid phenotypes in acute leukemia. Blood 1985;65:142-148.
5. Mirro J, Zipf TF, Pui C-H, et al. Acute mixed lineage leukemia: clinicopathologic correlations and prognostic significance. Blood 1985;66:1115-1123.
6. Kita K, Miwa H, Nakase K., et al. Clinical importance of CD7 expression in acute myelocytic leukemia. Blood 1993;81:2399-2405.
7. Sobol RE, Mick R, Royston I, et al. Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia. N Engl J Med 1987;316:1111-1117.
8. Wiersma SR, Ortega J, Sobel E, Weinberg KI. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood. N Engl J Med 1991;324:800-808.
9. Medeiros LJ, Herington RD, Gonzalez CH, Jaffe ES, Cossman J. My4 antibody staining of non-Hodgkin's lymphomas. Am J Clin Pathol 1991;95:363-368.
10. Morabito F, Prasthofer EF, Dunlap NE, Grossi CE, Tilden AB. Expression of myelomonocytic antigen on chronic lymphocytic leukemia B cells correlates with their ability to produce interleukin 1. Blood 1987;70:1750-1757.
11. Kita K, Nakase K, Miwa H, et al. Phenotypic characteristics of acute myelocytic leukemia associated with the t(8;21) (q22;q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. Blood 1992;80:470-477.
12. Bennett JM, Catovsky D, Daniel M-T, et al. Proposal for the classification of chronic (mature) B and T lymphoid leukaemias. J Clin Pathol 1989;42:567-584.
13. Nakase K, Kita K, Otsuji A, et al. Diagnostic and clinical importance of interleukin-2 receptor alpha chain expression on non-T-cell acute leukaemia cells. Br J Haematol 1992;80:317-326.
14. Asou H, Tashiro S, Hamamoto K, et al. Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8; 21 chromosome translocation. Blood 1991;77:2031-2036.
15. Kita K, Nasu K, Kamesaki H, et al. Phenotypic characterization and clinical evaluation of 15 patients with lymphoblastic lymphoma. Acta Hematol Jpn 1985;48:89-98.
16. Pui C-H, Frankel LS, Carroll AJ, et al. Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with with the t(4:l 1) (q21;q23): A collaborative study of 40 cases. Blood 1991;77:440-447.
17. Mirro J, Kitchingman G, Williams D, et al. Clinical and laboratory characteristics of acute leukemia with the 4; 11 translocation. Blood 1986;67:689-697.
18. Civin CI. Human monomyeloid cell membrane antigens. Exp Hematol 1990;18:461-467.
19. Stockinger H, Majdic O, Liszka K, et al. Exposure by desialylation of myeloid antigens on acute lymphoblastic leukemia cells. J Natl Cancer Inst 1984;73:7-11.
20. Lauria F, Raspadori D, Martinelli G, et al. Increased expression of myeloid antigen markers if adult acute lymphoblastic leukaemia patients: diagnostic and prognostic implications. Br J Haematol 1994;87:286-292.
21. Bennet JM, Catovsky D, Daniel M-T, et al. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO). Br J Haematol 1991;78:325-329.
22. Kurtzberg J, Waldmann TA, Davey MP, et al. CD7+, CD4-, CD8- acute leukemia: A syndrome of malignant pluripotent lymphohematopoietic cells. Blood 1989;73:381-390.
23. Kita K, Nishii K, Ohishi K, et al. Frequent gene expression of granulocyte colony-stimulating factor (G-CSF) receptor in CD7+ surface CD3- acute lymphoblastic leukemia. Leukemia 1993;7:1184-1190.
24. Nishii K, Kita K, Miwa H, et al. c-kit gene expression in CD7-positive acute lymphoblastic leukemia: close correlation with expression of myeloid-associated antigen CD13. Leukemia 1992;6:662-668.
25. Miwa H, Kita K, Nishii K, et al. Expression of MDR1 gene in acute leukemia cells: association with CD7+ acute myeloblastic leukemia/acute lymphoblastic leukemia. Blood 1993;82:3445-3451.
26. Yumura-Yagi K, Hara J, Kurahashi H, et al. Clinical significance of CD7 positive stem cell leukemia. Cancer 1991;68:2273-2280.
27. Hirsch-Ginsberg C, Childs C, Chang K-S, et al. Phenotypic and molecular heterogeneity in Philadelphia chromosome-positive acute leukemia. Blood 1988;71:186-195.
28. Paietta E, Gucalp R, Wiernik PE. Monosomy 7 in multilineage and acute lymphoblastic leukaemia. Br J Haematol 1991;79: 152-155.
29. Grogan TM, Durie BGM, Spier CM, Richter L, Vela E. Myelomonocytic antigen positive multiple myeloma. Blood 1989;73:763-769.
30. Ziegler-Heitbrock HWL, Pechumer H, Petersmann I, et al. CD14 is expressed and functional in human B cells. Eur J Immunol 1994;24:1937-1940.
31. Hanecak R, Zovich DC, Pattengale PK, Fan H. Differentiation in vitro of a leukemia virus-induced B-cell lymphoma into macrophages. Mol Cell Biol 1989;9:2264-2268.
32. Akashi K, Harada M, Shibuya T, et al. Simultaneous occurrence of myelomonocytic leukemia and multiple myeloma: Involvement of common leukemic progenitors and their developmental abnormality of lineage infidelity. J Cell Physiol 1991;148: 446-456.
33. Epstein J, Xiao H, He X-Y. Markers of multiple hematopoietic-cell lineages in multiple myeloma. N Engl J Med 1990;322:664-668.
34. Vescio RA, Hong CH, Cao I, et al. The hematopoietic stem cell antigen, CD34, is not expressed on the malignant cells in multiple myeloma. Blood 1994;84:3283-3290.
35. Fujii H, Yashige H, Misawa S, et al. Ph chromosome in a patient with non-leukemic non-Hodgkin B-cell lymphoma. Am J Hematol 1990;35:213-215.
36. Ziegler-Heitbrock HWL, Thiel E, Futterer A, et al. Establishment of a human cell line (Mono Mac6) with characteristics of mature monocytes. Int J Cancer 1988;41:456-461.